Condition
Crohn Disease of Small Intestine
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Terminated1
Unknown1
Completed1
Active Not Recruiting1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03142321Phase 4CompletedPrimary
Defining Predictors of RT Response to Vedolizumab in IBD
NCT07157436TerminatedPrimary
Implementation of Point Of Care UltraSound in the Assessment of Crohn's Disease -The POCUS Study
NCT06555042Recruiting
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
NCT06515171Active Not Recruiting
Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency Capsule
NCT05636657Unknown
Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
Showing all 5 trials